Cargando…

Serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity

INTRODUCTION: Obesity, defined by an excessive body fat accumulation, is a non-communicable condition attaining epidemic proportions in economically developed countries. OBJECTIVES: To provide evidence to the link between serotonin (5-HT), energy metabolism and the human obese phenotype, the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Palermo, S., Chiarantini, I., Cappellato, G., Arone, A., Massoni, L., Fantasia, S., Violi, M., Marazziti, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434516/
http://dx.doi.org/10.1192/j.eurpsy.2023.908
_version_ 1785091910215401472
author Palermo, S.
Chiarantini, I.
Cappellato, G.
Arone, A.
Massoni, L.
Fantasia, S.
Violi, M.
Marazziti, D.
author_facet Palermo, S.
Chiarantini, I.
Cappellato, G.
Arone, A.
Massoni, L.
Fantasia, S.
Violi, M.
Marazziti, D.
author_sort Palermo, S.
collection PubMed
description INTRODUCTION: Obesity, defined by an excessive body fat accumulation, is a non-communicable condition attaining epidemic proportions in economically developed countries. OBJECTIVES: To provide evidence to the link between serotonin (5-HT), energy metabolism and the human obese phenotype, the present study investigated the binding and function of the platelet 5-HT transporter (SERT), in relation to circulating insulin, leptin, glycolipid metabolic parameters and body-mass indices (BMIs, Kg m(-2)). METHODS: The study included an observational clinical cohort of 74 drug-free subjects (51W; 23M), recruited on the basis of divergent BMIs (16.5-54.8 Kg m(-2)). All subjects were tested for their blood glycolipid profile together platelet [(3)H]-paroxetine ([(3)H]-Par) binding and [(3)H]-5-HT reuptake measurements from April 1(st) to June 30(th) 2019. RESULTS: The [(3)H]-Par B(max) (fmol/mg proteins) was progressively reduced with increasing BMIs (p<.001), without changes in affinity. Moreover, B(max) was negatively correlated with BMI, waist/hip circumferences, triglycerides, glucose, insulin and leptin, while positively with HDL cholesterol (p<.01). The reduction of 5-HT uptake rate (V(max), pmol//min/10(9)platelets) amongst BMI groups was not statistically significant, but V(max) negatively correlated with leptin and uptake affinity values (p<.05). Besides, [(3)H]-Par affinity values positively correlated with glycaemia and triglycerides, while [(3)H]-5-HT reuptake affinity with glycaemia only (p<.05). Finally, these correlations were specific of obese subjects, while, from multivariate linear-regression analysis conducted on all subjects, insulin (p=.006) resulting negatively related to B(max) independently from BMI. CONCLUSIONS: The present findings would suggest the presence of a dysfunctional insulin/5-HT/leptin axis in obesity, differentially impinging the density, function and/or affinity of the platelet SERT, as the result of complex appetite/reward-related interactions between the brain, gut, pancreatic islets and adipose tissue. In addition, they support the foremost cooperation of insulin and 5-HT in maintaining energy homeostasis. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10434516
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104345162023-08-18 Serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity Palermo, S. Chiarantini, I. Cappellato, G. Arone, A. Massoni, L. Fantasia, S. Violi, M. Marazziti, D. Eur Psychiatry Abstract INTRODUCTION: Obesity, defined by an excessive body fat accumulation, is a non-communicable condition attaining epidemic proportions in economically developed countries. OBJECTIVES: To provide evidence to the link between serotonin (5-HT), energy metabolism and the human obese phenotype, the present study investigated the binding and function of the platelet 5-HT transporter (SERT), in relation to circulating insulin, leptin, glycolipid metabolic parameters and body-mass indices (BMIs, Kg m(-2)). METHODS: The study included an observational clinical cohort of 74 drug-free subjects (51W; 23M), recruited on the basis of divergent BMIs (16.5-54.8 Kg m(-2)). All subjects were tested for their blood glycolipid profile together platelet [(3)H]-paroxetine ([(3)H]-Par) binding and [(3)H]-5-HT reuptake measurements from April 1(st) to June 30(th) 2019. RESULTS: The [(3)H]-Par B(max) (fmol/mg proteins) was progressively reduced with increasing BMIs (p<.001), without changes in affinity. Moreover, B(max) was negatively correlated with BMI, waist/hip circumferences, triglycerides, glucose, insulin and leptin, while positively with HDL cholesterol (p<.01). The reduction of 5-HT uptake rate (V(max), pmol//min/10(9)platelets) amongst BMI groups was not statistically significant, but V(max) negatively correlated with leptin and uptake affinity values (p<.05). Besides, [(3)H]-Par affinity values positively correlated with glycaemia and triglycerides, while [(3)H]-5-HT reuptake affinity with glycaemia only (p<.05). Finally, these correlations were specific of obese subjects, while, from multivariate linear-regression analysis conducted on all subjects, insulin (p=.006) resulting negatively related to B(max) independently from BMI. CONCLUSIONS: The present findings would suggest the presence of a dysfunctional insulin/5-HT/leptin axis in obesity, differentially impinging the density, function and/or affinity of the platelet SERT, as the result of complex appetite/reward-related interactions between the brain, gut, pancreatic islets and adipose tissue. In addition, they support the foremost cooperation of insulin and 5-HT in maintaining energy homeostasis. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10434516/ http://dx.doi.org/10.1192/j.eurpsy.2023.908 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Palermo, S.
Chiarantini, I.
Cappellato, G.
Arone, A.
Massoni, L.
Fantasia, S.
Violi, M.
Marazziti, D.
Serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity
title Serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity
title_full Serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity
title_fullStr Serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity
title_full_unstemmed Serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity
title_short Serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity
title_sort serotonin, insulin, leptin and glycolipid metabolic factor’s relationship in obesity
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434516/
http://dx.doi.org/10.1192/j.eurpsy.2023.908
work_keys_str_mv AT palermos serotonininsulinleptinandglycolipidmetabolicfactorsrelationshipinobesity
AT chiarantinii serotonininsulinleptinandglycolipidmetabolicfactorsrelationshipinobesity
AT cappellatog serotonininsulinleptinandglycolipidmetabolicfactorsrelationshipinobesity
AT aronea serotonininsulinleptinandglycolipidmetabolicfactorsrelationshipinobesity
AT massonil serotonininsulinleptinandglycolipidmetabolicfactorsrelationshipinobesity
AT fantasias serotonininsulinleptinandglycolipidmetabolicfactorsrelationshipinobesity
AT violim serotonininsulinleptinandglycolipidmetabolicfactorsrelationshipinobesity
AT marazzitid serotonininsulinleptinandglycolipidmetabolicfactorsrelationshipinobesity